All > Osteoarthritis > Knee Osteoarthritis

Gel-Bead embolization for Osteoarthritis of the Knee

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Osteoarthritis of the KneeGel-Bead embolization - Device
Eligibility
18 - 75
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether or not transcatheter arterial embolization can help relieve pain and improve functionality in patients with mild to moderate knee osteoarthritis.

Eligible Conditions
  • Osteoarthritis of the Knee

Treatment Effectiveness

Effectiveness Progress

1 of 3

Similar Trials

1
amobarbital/Gel-One (one dose)
3
Benzoyl peroxide gel
1
NEAT!2

Study Objectives

1 Primary · 4 Secondary · Reporting Duration: Baseline and 6 months from treatment

Month 6
30-second chair stand test
6-minute walk test
Change in KOOS Quality of Life Scale
Change in knee-related functionality
Overall efficacy of treatment

Trial Safety

Safety Progress

1 of 3

Similar Trials

1
amobarbital/Gel-One (one dose)
3
Benzoyl peroxide gel
1
NEAT!2

Trial Design

1 Treatment Group

Gel-Bead Embolization
1 of 1

Experimental Treatment

15 Total Participants · 1 Treatment Group

Primary Treatment: Gel-Bead embolization · No Placebo Group · N/A

Gel-Bead Embolization
Device
Experimental Group · 1 Intervention: Gel-Bead embolization · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline and 6 months from treatment

Who is running the clinical trial?

Anish GhodadraLead Sponsor
Anish Ghodadra, MDPrincipal InvestigatorUniversity of Pittsburgh

Eligibility Criteria

Age 18 - 75 · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have a radiographic grade 1, 2, or 3 osteoarthritis in the knee in the last 6 months.
References

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top